Back
Regeneron Pharmaceuticals Stock Price Chart
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Sell
38
REGN
Regeneron Pharmaceuticals
Last Price:
$679.56
Seasonality Move:
-2.68%
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.
Regeneron Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 700.54 | Sell |
| 20-day SMA: | 708.39 | Sell |
| 50-day SMA: | 743.42 | Sell |
| 200-day SMA: | 957.85 | Sell |
| 8-day EMA: | 697.54 | Sell |
| 20-day EMA: | 711.83 | Sell |
| 50-day EMA: | 763.86 | Sell |
| 200-day EMA: | 897.17 | Sell |
Regeneron Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -17.58 | Sell |
| Relative Strength Index (14 RSI): | 38.73 | Sell |
| Chaikin Money Flow: | 110639 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (697.43 - 728.15) | Sell |
| Bollinger Bands (100): | (724.05 - 1067.35) | Sell |
Regeneron Pharmaceuticals Technical Analysis
| Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Regeneron Pharmaceuticals Stock
Is Regeneron Pharmaceuticals Stock a Buy?
-
Regeneron Pharmaceuticals share price is 687.80 while REGN 8-day simple moving average is 700.54, which is a Sell signal.
-
The stock price of REGN is 687.80 while Regeneron Pharmaceuticals 20-day SMA is 708.39, which makes it a Sell.
-
Regeneron Pharmaceuticals 50-day simple moving average is 743.42 while REGN share price is 687.80, making it a Sell technically.
-
REGN stock price is 687.80 and Regeneron Pharmaceuticals 200-day simple moving average is 957.85, creating a Sell signal.
REGN Technical Analysis vs Fundamental Analysis
Sell
38
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a SellThe current Regeneron Pharmaceuticals [REGN] share price is $687.80. The Score for REGN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Regeneron Pharmaceuticals Stock Info
Market Cap:
75.6B
Price in USD:
687.80
Share Volume:
1.1M
Regeneron Pharmaceuticals 52-Week Range
52-Week High:
1,211.20
52-Week Low:
666.25
Sell
38
Regeneron Pharmaceuticals (REGN)
is a Sell
Regeneron Pharmaceuticals Share Price Forecast
-
What is the Regeneron Pharmaceuticals stock price today?The Regeneron Pharmaceuticals stock price is 687.80 USD today.
-
Will REGN stock go up or go down?Regeneron Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Regeneron Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regeneron Pharmaceuticals is overvalued.
Is Regeneron Pharmaceuticals Stock a Buy?
-
Regeneron Pharmaceuticals share price is 687.80 while REGN 8-day exponential moving average is 697.54, which is a Sell signal.
-
The stock price of REGN is 687.80 while Regeneron Pharmaceuticals 20-day EMA is 711.83, which makes it a Sell.
-
Regeneron Pharmaceuticals 50-day exponential moving average is 763.86 while REGN share price is 687.80, making it a Sell technically.
-
REGN stock price is 687.80 and Regeneron Pharmaceuticals 200-day simple moving average is 897.17, creating a Sell signal.
Fundamental Analysis of Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $1.74 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $4.58 per share.
Technical Analysis of Regeneron Pharmaceuticals
Should I short Regeneron Pharmaceuticals stock?
-
REGN Moving Average Covergence Divergence (MACD) indicator is -17.58, suggesting Regeneron Pharmaceuticals is a Sell
-
Regeneron Pharmaceuticals Relative Strength Index (RSI) is 38.73, which suggest Regeneron Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Regeneron Pharmaceuticals is (697.43 - 728.15), which suggest Regeneron Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Regeneron Pharmaceuticals is (724.05 - 1067.35), which suggest Regeneron Pharmaceuticals is a Sell
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.